Oaktree Acquisition Corp. III Life Sciences (OACC) Institutional Ownership $10.47 +0.11 (+1.06%) As of 08/13/2025 10:11 AM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$49.68MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$5.43M Get OACC Insider Trade Alerts Want to know when executives and insiders are buying or selling Oaktree Acquisition Corp. III Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OACC Institutional Buying and Selling by Quarter Oaktree Acquisition Corp. III Life Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025Clear Street LLC22,000$230K0.0%+265.1%0.098% 8/12/2025 JPMorgan Chase & Co.199,776$2.09M0.0%N/A0.891% 8/8/2025 Alberta Investment Management Corp500,000$5.24M0.1%N/A2.230% 6/27/2025Goldman Sachs Group Inc.529,535$5.42M0.0%N/A2.362% 5/29/2025DLD Asset Management LP350,000$3.58M0.2%+100.0%1.561% 5/16/2025Goldman Sachs Group Inc.529,535$5.42M0.0%N/A2.361% 5/16/2025Millennium Management LLC473,914$4.85M0.0%N/A2.113% 5/16/2025AQR Arbitrage LLC1,450,750$14.80M0.4%-26.7%6.469% 5/15/2025 Gritstone Asset Management LLC398,634$4.08M4.6%-0.3%1.778% 5/15/2025Ghisallo Capital Management LLC450,000$4.59M0.4%N/A2.007% Get the Latest News and Ratings for OACC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025Linden Advisors LP600,000$6.12M0.0%N/A2.676% 5/15/2025Driehaus Capital Management LLC900,000$9.18M0.1%N/A4.013% 5/13/2025 Kepos Capital LP55,000$563K0.5%N/A0.245% 5/13/2025 HighTower Advisors LLC136,989$1.40M0.0%N/A0.611% 5/12/2025Mizuho Securities USA LLC200,000$2.02M0.0%N/A0.892% 5/7/2025 Picton Mahoney Asset Management75,000$767K0.0%N/A0.334% 2/19/2025Toronto Dominion Bank1,436,900$14.36M0.0%N/A6.408% 2/17/2025Two Sigma Investments LP437,500$4.36M0.0%N/A1.951% 2/17/2025TENOR CAPITAL MANAGEMENT Co. L.P.300,000$2.99M0.0%N/A1.338% 2/17/2025Toronto Dominion Bank1,436,900$14.36M0.0%N/A6.409% 2/17/2025Sculptor Capital LP250,000$2.49M0.0%N/A1.115% 2/17/2025Lighthouse Investment Partners LLC300,000$3.04M0.1%N/A1.338% 2/17/2025K2 Principal Fund L.P.195,292$1.95M0.2%N/A0.871% 2/14/2025AQR Arbitrage LLC1,980,285$19.74M0.4%N/A8.831% 2/14/2025Shaolin Capital Management LLC550,000$5.48M0.1%N/A2.453% (Data available from 1/1/2016 forward) OACC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OACC shares? During the previous two years, 22 institutional investors and hedge funds held shares of Oaktree Acquisition Corp. III Life Sciences. The most heavily invested institutionals were AQR Arbitrage LLC ($14.80M), Toronto Dominion Bank ($14.36M), Driehaus Capital Management LLC ($9.18M), Linden Advisors LP ($6.12M), Shaolin Capital Management LLC ($5.48M), Goldman Sachs Group Inc. ($5.42M), and Alberta Investment Management Corp ($5.24M).Learn more on Oaktree Acquisition Corp. III Life Sciences' institutional investors. Which institutional investors have been buying Oaktree Acquisition Corp. III Life Sciences' stock? Of the 21 institutional investors that purchased Oaktree Acquisition Corp. III Life Sciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($2.87M), AQR Arbitrage LLC ($1.98M), Goldman Sachs Group Inc. ($1.06M), Driehaus Capital Management LLC ($900K), Linden Advisors LP ($600K), Shaolin Capital Management LLC ($550K), and Alberta Investment Management Corp ($500K). How much institutional buying is happening at Oaktree Acquisition Corp. III Life Sciences? Institutional investors have bought a total of 11,727,601 shares in the last 24 months. This purchase volume represents approximately $49.68M in transactions. Which of Oaktree Acquisition Corp. III Life Sciences' major shareholders have been selling company stock? The following institutional investors have sold Oaktree Acquisition Corp. III Life Sciences stock in the last 24 months: AQR Arbitrage LLC ($529.54K), and Gritstone Asset Management LLC ($1.37K). How much institutional selling is happening at Oaktree Acquisition Corp. III Life Sciences? Institutional investors have sold a total of 530,901 shares in the last 24 months. This volume of shares sold represents approximately $5.43M in transactions. Related Companies Centerspace Institutional Ownership Orchid Island Capital Institutional Ownership Franklin BSP Realty Trust Institutional Ownership Patria Investments Institutional Ownership Noah Institutional Ownership NexPoint Residential Trust Institutional Ownership Associated Capital Group Institutional Ownership Getty Images Institutional Ownership Ares Acquisition Corporation II Institutional Ownership TPG RE Finance Trust Institutional Ownership This page (NASDAQ:OACC) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access